We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 9,731 results
  1. Modulation of Multidrug Resistance Protein 1-mediated Transport Processes by the Antiviral Drug Ritonavir in Cultured Primary Astrocytes

    The Multidrug Resistance Protein 1 (Mrp1) is an ATP-dependent efflux transporter and a major facilitator of drug resistance in mammalian cells during...

    Christian Arend, Isabell L. Grothaus, ... Ralf Dringen in Neurochemical Research
    Article Open access 21 August 2023
  2. Different Efflux Pump Systems in Acinetobacter baumannii and Their Role in Multidrug Resistance

    Several infections, such as pneumonia, urinary tract infections (UTIs), as well as bloodstream, skin, and soft tissue infections, are caused by...
    Saroj Sharma, Vaishali Kaushik, ... Vishvanath Tiwari in Advances in Microbiology, Infectious Diseases and Public Health
    Chapter 2023
  3. Nano-Cargo Boarded Defensins to Combat Multidrug Resistance

    Antibiotics have transformed the world of medical sciences instantaneously after their discovery. In the last few decades, the emergence of multidrug...
    Saurabh Bhorkade, Pawan Kumar Pandey, ... Sanyog Jain in Emerging Modalities in Mitigation of Antimicrobial Resistance
    Chapter 2022
  4. Alpha-1 antitrypsin expression is upregulated in multidrug-resistant cancer cells

    Identification of the signature molecular profiles involved in therapy resistance is of vital importance in develo** new strategies for treatments...

    Aleksandra Divac Rankov, Sofija Jovanović Stojanov, ... Mila Ljujić in Histochemistry and Cell Biology
    Article 19 December 2022
  5. Evolution and the Role of SXT-Related Integrative Conjugative Elements in Multidrug-Resistant Vibrio cholerae

    The emergence of various classes of antibiotics over the years and their widespread use in clinical and food sectors resulted in antimicrobial...
    Minimol V. A., Pankaj Kishore, Mukteswar Prasad Mothadaka in Handbook on Antimicrobial Resistance
    Living reference work entry 2023
  6. Key genes and molecular mechanisms related to Paclitaxel Resistance

    Paclitaxel is commonly used to treat breast, ovarian, lung, esophageal, gastric, pancreatic cancer, and neck cancer cells. Cancer recurrence is...

    Adel I. Alalawy in Cancer Cell International
    Article Open access 13 July 2024
  7. Y-Box-Binding Protein-1

    Various reports have proved that Y-box-binding protein-1 (YB-1) is a protein with multiple roles including transcription/translation regulation of...
    Vinoth Prasanna Gunasekaran, Sudarshan Naidu, Kumari Nishi in Handbook of Oxidative Stress in Cancer: Therapeutic Aspects
    Living reference work entry 2022
  8. Evolution and the Role of SXT-Related Integrative Conjugative Elements in Multidrug-Resistant Vibrio cholerae

    The emergence of various classes of antibiotics over the years and their widespread use in clinical and food sectors resulted in antimicrobial...
    V. A. Minimol, Pankaj Kishore, Mukteswar Prasad Mothadaka in Handbook on Antimicrobial Resistance
    Reference work entry 2023
  9. Clinical manifestations, antimicrobial resistance and genomic feature analysis of multidrug-resistant Elizabethkingia strains

    Background

    Elizabethkingia is emerging as an opportunistic pathogen in humans. The aim of this study was to investigate the clinical epidemiology,...

    Chongyang Wu, Li **ong, ... Yi **e in Annals of Clinical Microbiology and Antimicrobials
    Article Open access 10 April 2024
  10. Role of Plant Secondary Metabolites as Modulators of Multidrug Resistance in Cancer Therapy

    Cancer is one of the leading causes of global mortality and morbidity. It is caused by dysregulation of key cellular processes. Treatment of cancer...
    Mayank Chaudhary in Plant Secondary Metabolites
    Chapter 2022
  11. Role of Gold Nanoparticles Against Multidrug Resistance (MDR) Bacteria: An Emerging Therapeutic Revolution

    Multidrug resistance (MDR) due to extensive futile use of antibiotics exhibits as an emerging menace to human health toward diagnosis and treatment....
    Kaushik Kumar Bharadwaj, Bijuli Rabha, ... Arabinda Ghosh in Emerging Modalities in Mitigation of Antimicrobial Resistance
    Chapter 2022
  12. Intracellular Compartments and Drug Resistance

    Intracellular compartments play a pivotal role in cellular function, housing diverse organelles that contribute to essential processes such as...
    Safiya Mehraj, Shariqa Jan, ... Sameer Ullah Khan in Drug Resistance in Cancer: Mechanisms and Strategies
    Chapter 2024
  13. Multidrug resistance genes screening of pancreatic ductal adenocarcinoma based on sensitivity profile to chemotherapeutic drugs

    Backgrounds

    Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancer types and chemotherapeutic drug resistance is a stumbling block...

    Bangbo Zhao, Cheng Qin, ... Weibin Wang in Cancer Cell International
    Article Open access 01 December 2022
  14. Mechanisms of Drug Resistance in Breast Cancer

    The incidence of breast cancer has increased over the past decades making it the most common cancer in females worldwide. Multidrug resistance (MDR)...
    McCabe Michelle, Dineo Disenyane, ... Zodwa Dlamini in Overcoming Breast Cancer Therapy Resistance
    Chapter 2024
  15. Y-Box-Binding Protein-1

    Various reports have proved that Y-box-binding protein-1 (YB-1) is a protein with multiple roles including transcription/translation regulation of...
    Vinoth Prasanna Gunasekaran, Sudarshan Naidu, Kumari Nishi in Handbook of Oxidative Stress in Cancer: Therapeutic Aspects
    Reference work entry 2022
  16. Low NCOR2 levels in multiple myeloma patients drive multidrug resistance via MYC upregulation

    MYC upregulation is associated with multidrug refractory disease in patients with multiple myeloma (MM). We, isolated patient-derived MM cells with...

    Tomoaki Mori, Rakesh Verma, ... Noopur S. Raje in Blood Cancer Journal
    Article Open access 04 December 2021
  17. Metal Nanoparticles As Alternative Antimicrobial Agents to Combat Multidrug Resistance Bacteria

    The rise of multidrug-resistant (MDR) bacteria poses a significant global health concern. The development of novel and effective antimicrobial agents...
    Chapter 2024
  18. Polymer-Based Nanomaterials Against Multidrug-Resistant Bacteria

    Currently, there are major developments in the fields of medicine and biomedical engineering to mitigate the spreading of resistant bacteria and the...
    Ana R. M. Ribeiro, Marta O. Teixeira, ... Helena P. Felgueiras in Nanotechnology Based Strategies for Combating Antimicrobial Resistance
    Chapter 2024
  19. Multidrug-resistant Gram-negative clinical isolates with reduced susceptibility/resistance to cefiderocol: which are the best present and future therapeutic alternatives?

    Purpose

    To evaluate the different present and future therapeutic β-lactam/β-lactamase inhibitor (BL/BLI) alternatives, namely aztreonam-avibactam,...

    Christophe Le Terrier, Samanta Freire, ... Laurent Poirel in European Journal of Clinical Microbiology & Infectious Diseases
    Article Open access 14 December 2023
Did you find what you were looking for? Share feedback.